A synergism between PARP1 and phosphorylated Erk mediating IEG (immediate early gene) expression has been recently reported in cerebral neurons and cardiomyocytes. Stimulation induced PARP-Erk synergism was required for IEG expression underlying synaptic plasticity and long-term memory acquisition during learning. It was similarly required for cardiomyocytes development. Here, we identified this mechanism in Erk-induced gene expression promoting proliferation. This mechanism can be targeted in malignant cells.
INTRODUCTION
Numerous signal transduction mechanisms target the MAP (mitogen activated protein) kinase phosphorylation cascade in a variety of cell types [1, 2] . In the absence of NLS (nuclear localization signal), phosphorylated Erks shuttle between the cytoplasm and the nucleus, with tendency to translocate to the nucleus in response to stimulation [3] . A possible binding of phosphorylated Erks to any nuclear protein would retain their activity in the nucleus [3, 4] . On the basis of recent findings, we suggest that the most abundant nuclear protein PARP1 acts as an anchoring protein of phosphorylated Erk2 [5] [6] [7] . Docking sites of phosphorylated Erk were identified in PARP1 domains, which are not involved in the binding of PARP1 to DNA single strand breaks [7] . Moreover, phosphorylated Erk2 induced PARP1 activation and polyADP-ribosylation in cell-free systems and in cerebral neurons and cardiomyocytes [5] [6] [7] . PARP1 bound to phosphorylated Erk2 was highly polyADP-ribosylated in the presence of very low NAD concentrations due to intramolecular modifications enhancing its affinity for NAD [5, 6] . Activated PARP1 polyADP-ribosylate its prominent substrate in the chromatin, linker histone H1 [5] [6] [7] . PolyADP-ribosylated H1 repulsion from the negatively charged DNA [7, 8] caused a local chromatin relaxation, exposing transcription factors to phosphorylation by the PARP-bound phosphorylated Erk, as indicated by chromatin immunoprecipitation (ChIP assay) technique in electrically stimulated cultured cortical neurons [7] . Phosphorylated transcription factors Elk1 and CREB induced histone H4 acetylation and IEG expression implicated in synaptic plasticity [5, 6, 9, 10] . This mechanism may explain the role of H1 polyADPribosylation in PARP1 dependent memory acquisition [11] [12] [13] , as well as the lack of long-term memory acquisition in PARP1-KO mice [7] .
Here, we identified the same mechanism active in proliferating mouse embryonic fibroblasts (MEF).
RESULTS AND DISCUSSION
In proliferating cells, Erk-induced c-fos expression may activate transcription factor AP1 (combined of phosphorylated c-Fos protein bound to c-Jun). AP-1 promotes cyclinD expression, and cdk1 activation implicated in the initiation of mitosis [14] [15] [16] [17] . Here we found that c-fos expression was governed by PARP1-Erk binding and synergism in stimulated MEF.
In proliferating cells, stimulation-induced PKC phosphorylation mediates proliferation via a signal transduction implicating PKC binding to diacylglycerol
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phosphate (DAG) in the cell membrane [14, 15] . In the depicted experiments, PKC binding to DAG was mimicked by its binding to phorbol esther (PMA). The resulting PKC phosphorylation mediates proliferation via downstream phosphorylation of Erk [14, 15] .
In MEF, PMA induced Erk phosphorylation was accompanied by Erk translocation into the nucleus ( These results are in line with Erk-bound PARP1 activation and PARP1-dependent phosphorylated Erk activity promoting the expression of cfos (Figure 2A) , which was previously observed in a cell free system ( Figure 2B ).
PARP1 silencing similarly suppressed a stimulation induced Elk phosphorylation in the nuclei of MEF stimulated by PMA, and human breast cancer cells MCF-7 ( Figure 3A and 3B) . Similarly, PARP1 silencing suppressed Erk induced IEG expression in stimulated cortical neurons ( Figure 3C ). PARP1 inhibitors although not interfering with PARP1 binding to phosphorylated Erk [5] [6] [7] , could prevent chromatin relaxation due to polyADP-ribosylation of linker histone H1 [5] [6] [7] [8] . In accordance, a transient PARP1 inhibition preceding stimulation with PMA, suppressed c-Fos synthesis sampled 30 min after stimulation ( Figure 3D ).
These results support the notion that PARP1 is required for preserving the activity of phosphorylated Erk in nuclei of stimulated MEF, and PARP1 activity mediates Erk-induced cFos synthesis promoting proliferation ( Figure 4 ). This PARP1-Erk synergism could be a new target of treatments aiming to suppress proliferation [18] . 
MATERIALS AND METHODS

Antibodies and recombinant proteins
PARP1 and its recombinant domains were immunolabeled by a monoclonal antibody (Serotec, Cat # MCA1522; Oxford, UK), and a polyclonal antibody (Alexis, Cat # ALX210-302). ADP-ribose polymers (PAR) were immunolabeled (Alexis, cat #961004). Erk2 was immunolabeled by antibody directed against the c-terminal of Erk2 (#sc-154; Santa Cruz Biotechnology, CA, USA), phosphorylated Erk1/2, α-actin (Sigma), Elk1 and phosphorylated Elk1 and cFos were immunolabeled by antibodies purchased from Cell Signaling Technologies (MA, USA). First antibodies were labeled by fluorescent secondary antibody: CyTM2 (green) or fluorescent CyTM3 (red) conjugated affinity pure goat-anti-rabbit or goat anti-mouse secondary antibodies (Jackson ImmunoResearch). Recombinant PARP1 domains were prepared in the lab of Dr Francoise Dantzer (Strasbourg, France). Recombinant phosphorylated Erk2 was prepared in the lab of Prof Seger, as described before [5] .
Recombinants Elk1 (Elk1fusion protein lacking the DNA-binding domain of Elk; Elk1 residues 307−428 coupled to GST; Cell Signaling Technologies). ssDNA was from Sigma (salmon sperm DNA carrying numerous single strand breaks) [5] .
PARP1 activation is measured by [ 32 P]polyADPribosylation of PARP1 in nuclear extracts of MEF incubated with [
32 P]NAD (1 μCi/sample; 1000 mCi/mmol; Amersham, UK) as described before [19] . It is also indicated by immunolabeling with antibodies directed against ADP-ribose polymers or antibodies directed against PARP1 [19] .
Erk-induced PARP1 polyADP-ribosylation in a cell-free system has been described before [5, 6] . Recombinant PARP1 (100 ng/sample) was activated in the presence of [ 32 P]NAD (1000 Ci/mmol; 1 mCi/sample; 20 nM) or unlabeled NAD, ATP (1 mM) and recombinant phosphorylated Erk2 (100 ng/sample). Recombinant Elk1 (600 ng/sample) was phosphorylated in this system by recombinant phosphorylated Erk2.
PARP1 silencing by siRNA has been described before [5] . Two sequences, aa800-807 and aa890-897, in the PARP1 catalytic domain were targeted for PARP1 silencing. PARP1 targeted siRNA was prepared by Darmacon (Lafayette CO, USA). For control we used a non-specific siRNA#2 (non-spec. rat siRNA; Darmacon). Cells in cell culture were transfected by XtremeGENE siRNA transfection reagent (Cat no. 04476093001, Roche Diagnostic, GmbH Mannheim, Germany). PARP1 silencing was achieved 72 hours after transfection with 100-200 nM siRNA.
Preparation of MEF from normal and PARP1 KO mice. PARP1(−/+) 129/Sv mice were donated by Dr Dantzer (Strasbourg) and bred for PARP1 (−/−) mice in Cohen-Armon's lab (Tel-Aviv University) under the rules and regulations of the Institutional Animal Care and Use Committee. Mouse embryonic fibroblasts were prepared from normal and PARP-KO MEF according to a procedure developed in the lab of Dr. Dantzer [20] .
Nuclear protein extracts were prepared according to a procedure described before [7, 21] .
Treatment with PMA. MEF were treated with PMA (phorbol esther; 200 nM; 20 min) in serum deprived medium. PMA was then 5-times diluted by adding normal medium, and crude nuclei were prepared from MEF after various incubation periods with diluted PMA (40 nM).
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